Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals.

Arber C, Abhyankar H, Heslop HE, Brenner MK, Liu H, Dotti G, Savoldo B.

Gene Ther. 2013 Sep;20(9):958-62. doi: 10.1038/gt.2013.25. Epub 2013 May 23.

3.

Phenotype and functional evaluation of ex vivo generated antigen-specific immune effector cells with potential for therapeutic applications.

Han S, Huang Y, Liang Y, Ho Y, Wang Y, Chang LJ.

J Hematol Oncol. 2009 Aug 6;2:34. doi: 10.1186/1756-8722-2-34.

4.

A registry of HLA-typed donors for production of virus-specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune-compromised patients.

Li Pira G, Ivaldi F, Starc N, Landi F, Rutella S, Locatelli F, Sacchi N, Tripodi G, Manca F.

Transfusion. 2014 Dec;54(12):3145-54. doi: 10.1111/trf.12754. Epub 2014 Jul 20.

PMID:
25041366
5.

Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.

Zandvliet ML, van Liempt E, Jedema I, Kruithof S, Kester MG, Guchelaar HJ, Falkenburg JH, Meij P.

J Immunother. 2011 Apr;34(3):307-19. doi: 10.1097/CJI.0b013e318213cb90.

PMID:
21389867
6.
9.

High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice.

Kim JH, Lee SR, Li LH, Park HJ, Park JH, Lee KY, Kim MK, Shin BA, Choi SY.

PLoS One. 2011;6(4):e18556. doi: 10.1371/journal.pone.0018556. Epub 2011 Apr 29.

10.

Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells.

Mishra S, Losikoff PT, Self AA, Terry F, Ardito MT, Tassone R, Martin WD, De Groot AS, Gregory SH.

Vaccine. 2014 May 30;32(26):3285-92. doi: 10.1016/j.vaccine.2014.03.083. Epub 2014 Apr 8.

PMID:
24721533
11.

Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.

Zamorano PI, Wigdorovitz A, Pérez Filgueira DM, Escribano JM, Sadir AM, Borca MV.

Vaccine. 1998 Apr;16(6):558-63.

PMID:
9569465
12.

Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.

Torseth JW, Cohen GH, Eisenberg RJ, Berman PW, Lasky LA, Cerini CP, Heilman CJ, Kerwar S, Merigan TC.

J Virol. 1987 May;61(5):1532-9.

13.

Modulation of T-cell reactivity to synthetic peptide analogues of foot-and-mouth disease virus in sheep by amino acid substitutions.

Flynn JN, Harkiss GD, Moore D, DiMarchi R.

Vet Immunol Immunopathol. 1992 Mar;31(3-4):255-66.

PMID:
1375405
14.

Multiple antigenic peptides based on H-2K(b)-restricted CTL epitopes from murine heparanase induce a potent antitumor immune response in vivo.

Tang XD, Wang GZ, Guo J, Lü MH, Li C, Li N, Chao YL, Li CZ, Wu YY, Hu CJ, Fang DC, Yang SM.

Mol Cancer Ther. 2012 May;11(5):1183-92. doi: 10.1158/1535-7163.MCT-11-0607. Epub 2012 Mar 21.

15.

Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markers.

Leibold J, Feucht J, Halder A, Stevanovic S, Kayser S, Handgretinger R, Feuchtinger T.

J Immunother. 2012 Nov-Dec;35(9):661-9. doi: 10.1097/CJI.0b013e318270e112.

PMID:
23090075
16.

T cell recognition of HIV synthetic peptides in a natural infection.

Schrier RD, Gnann JW Jr, Landes R, Lockshin C, Richman D, McCutchan A, Kennedy C, Oldstone MB, Nelson JA.

J Immunol. 1989 Feb 15;142(4):1166-76.

PMID:
2783706
17.

Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum.

Behr C, Sarthou JL, Rogier C, Trape JF, Dat MH, Michel JC, Aribot G, Dieye A, Claverie JM, Druihle P, et al.

J Immunol. 1992 Nov 15;149(10):3321-30.

PMID:
1431109
18.

Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.

Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B.

J Immunol Methods. 2014 Jun;408:101-13. doi: 10.1016/j.jim.2014.05.011. Epub 2014 May 28.

PMID:
24877879
19.

Induction of antiviral cytotoxic T cells by plasmacytoid dendritic cells for adoptive immunotherapy of posttransplant diseases.

Aspord C, Laurin D, Richard MJ, Vie H, Chaperot L, Plumas J.

Am J Transplant. 2011 Dec;11(12):2613-26. doi: 10.1111/j.1600-6143.2011.03722.x. Epub 2011 Aug 29.

20.

Influenza virus-specific TCR-transduced T cells as a model for adoptive immunotherapy.

Berdien B, Reinhard H, Meyer S, Spöck S, Kröger N, Atanackovic D, Fehse B.

Hum Vaccin Immunother. 2013 Jun;9(6):1205-16. doi: 10.4161/hv.24051. Epub 2013 Feb 21.

Supplemental Content

Support Center